New interventional techniques for adenomyosis

Jaron Rabinovici, Elizabeth A Stewart
Best practice & research. Clinical obstetrics & gynaecology · 2006 · vol. 20(4) , pp. 617–636 · doi:10.1016/j.bpobgyn.2006.02.002 · PMID:16934530 · W2123795182
review OA: closed CC0 ⤵ 42 in-corpus citations
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed
⚙ AI-generated summary by claude@2026-06, 2026-06-08 ⓘ

This paper explores novel interventional techniques developed for the treatment of adenomyosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

mesh:D004715adenomyosis

MeSH descriptors

Endometriosis Uterine Diseases Adult Contraceptives, Oral, Synthetic Contraceptives, Oral, Synthetic Danazol Danazol Diagnosis, Differential Embolization, Therapeutic Embolization, Therapeutic Endometriosis Endometriosis Estrogen Antagonists Estrogen Antagonists Female Gonadotropin-Releasing Hormone Gonadotropin-Releasing Hormone Gonadotropin-Releasing Hormone Gynecologic Surgical Procedures Gynecologic Surgical Procedures

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (88)

Cited by (42)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-04T00:00:01.174412+00:00
pubmed
last seen: 2026-05-13T22:15:12.369988+00:00
License: CC0 · commercial use OK